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The use of endovenous procedures to treat superficial venous reflux disease in an exclusively outpatient setting has been
growing in popularity during the last decade. Incorporating outpatient venous procedures into an existing vascular
surgery practice is a logical step and provides optimal patient care by using the combined expertise and knowledge of
devoted vascular surgeons and dedicated supporting staff. This affords the opportunity to treat patients comprehensively
and to streamline the evaluation and treatment process for patients with virtually all stages of chronic venous
insufficiency. Successful establishment of an outpatient vein care clinic involves making well-informed decisions about
workspace, staffing, acquisition of equipment, optimization of reimbursement, and patient recruitment. Separation of the
venous practice from the arterial practice both geographically and temporally is critical to success because the clinical and
operational needs of these two groups of patients are very different and because the vein practice in many situations may
become so robust that it erodes physicians’ participation in the arterial side of the vascular practice. In addition to
favorable clinical results and increased patient demand, procedures performed on an outpatient basis can be expected to
significantly increase revenues. With proper strategy and organization, an outpatient vein practice can round out the
existing vascular practice and be a profitable adjunct to an already established vascular surgery practice. ( J Vasc Surg
2009;50:225-30.)With the introduction and advancement of minimally
invasive procedures during the last decade, few specialties
have experienced such dramatic change in the nature of
their practice as vascular surgery. Favorable clinical results
combined with increased patient demand for minimally
invasive therapies have resulted in an increased application
of endovenous procedures in the treatment of venous dis-
ease1-4 (Table I). This shift in technology has facilitated not
only the creation of outpatient vein clinics but also cross-
specialty participation in the management of venous disor-
ders.
Technologic innovations in the treatment of venous
disease have mirrored similar developments in the treat-
ment of arterial disease, and vascular specialists in both
areas have faced the challenges attendant with this. Specif-
ically, nonvascular specialists with an incomplete knowl-
edge base are performing procedures on vascular struc-
tures.
The delivery of optimal care to patients with venous
disease is best accomplished by physicians, usually vascular
surgeons, who have both the technical skills and the knowl-
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Alternatively, several 1-year fellowships are now available in
the United States that provide appropriate training to those
from nonvascular backgrounds.
Because the initial clinical presentation and the natural
history of venous disease varies in its extent and severity,
ranging from spider veins to limb-threatening active ulcer-
ations, treatment should be always undertaken within the
context of a full understanding of the basic molecular and
hemodynamic mechanisms underlying superficial reflux
disease.5-7 The endovascular ablation of incompetent ve-
nous segments allows the normalization of the hemody-
namics of the lower extremity by removing the source of
venous hypertension and may eliminate or reduce progres-
sion of reflux to other venous segments. In addition, the
decision for intervention has to take into account the degree
and distribution of venous reflux or obstruction, the relation-
ship between deep and superficial venous insufficiency, the
presence of other serious medical conditions, and patient’s
current functional status.8-12
In addition to the required technical skills and clinical
judgment, an effective operational strategy and organization
are critical components in the processes of establishing and
operating a vein clinic in the setting of an existing vascular
practice. The major strategic aspects of incorporating outpa-
tient venous procedures into a vascular surgery practice in-
clude designation of the appropriate workspace, the purchase
of equipment, staffing, optimization of reimbursement and
patient recruitment.
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A single location for physician encounters, ultrasound
evaluation, and procedures is optimal for both practice
efficiency and patient convenience. If this is not possible in
the early stages of practice development, the two may be
separated initially. In addition, it is optimal to separate the
evaluation and treatment of cohorts of patients with arterial
and venous disease for a number of reasons. Patients with
venous disease frequently do not perceive themselves as
being ill and, for the most part, are healthier than their
counterparts with arterial disease. Thus, segregating them
from patients with arterial disease and other serious medical
conditions is important to provide a more satisfying patient
experience.
In addition, a specialized staff with experience in the
evaluation and treatment of venous disease is becoming
more important given the rapid development of increas-
ingly sophisticated therapies for venous disease. The duplex
ultrasound evaluation of patients with venous disease re-
quires extensive experience, an understanding of the rela-
tionship of venous anatomy to pathology, and a familiarity
with the procedures performed for venous reflux. Depend-
ing on the number of physicians in the practice with an
interest in venous disease, rotation to this clinic on a regular
basis might sustain a full-time staff.
If a separate clinic facility and staff are not supported by
patient volume initially, focused evaluation of patients with
venous disease can be provided by the existing vascular
clinic space and staff by designating a separate day or
half-day of clinic and vascular laboratory time specifically
dedicated to patients with venous disorders. As the practice
grows, however, it is highly beneficial to have a separate
space where both patient evaluation and treatment are
done. As will be discussed later, performance of procedures
in a nonfacility is crucial to maximal reimbursement, and
offering all services in one location affords maximal patient
convenience and satisfaction.
PROCEDURAL SPACE
In contrast to procedures performed for arterial disease,
which require sedation and monitoring and may be associ-
ated with significant complications requiring urgent inter-
vention, endovenous procedures are characterized by short
Table I. United States Food and Drug Administration ap
Year Manufacturer
1999 VNUS Med Tech, Sunnyvale, Calif VN
2002 Diomed, Andover, Mass EVL
2002 Biolitec Inc, East Longmeadow, Mass ELV
2002 AngioDynamics, Queensbury, NY Ven
2003 Dornier, Germering, Germany Med
2003 Vascular Solutions, Minneapolis, Minn Var
2005 CoolTouch, Roseville, Calif CTE
2007 VNUS Med Tech, Sunnyvale, Calif VN
EVLA, Endovenous laser ablation; RFA, radiofrequency ablation; RFSA, raprocedure times and virtually no major perioperative oracute postoperative complications, and can be performed
under local anesthesia. Therefore, the optimal setting for
venous procedures is an outpatient setting, and specifically,
for the purposes of optimal reimbursement, a nonfacility.
Space requirements include a waiting room and reception-
ist, a nurse or medical assistant to check the patient in, and
a surgical assistant. Often the same person can both check
the patient in and assist in the procedure.
The procedure room must be large enough to contain
a procedure table, generator box, and ultrasound machine
and to allow the movement of staff around the equipment.
Additional requirements are adequate room for the patient
to ambulate for 20 minutes after the procedure and storage
for equipment such as catheters and other necessities.
Although serious complications during venous proce-
dures are very rare, appropriate equipment and staff must
be available to treat them if they arise. Such equipment
includes an emergency resuscitation (crash) cart, oxygen
tank, and electrocardiography machine. Ammonium cap-
sules and oxygen are helpful in treating vasovagal episodes,
which are not uncommon during venous ablation proce-
dures.
EQUIPMENT
The minimum required equipment for a vein practice
includes at least one ultrasoundmachine, a procedure table,
a generator for thermal ablation, and instruments that can
be used if a cutdown is required during an ablation proce-
dure. If the existing vascular practice does not include a
vascular laboratory, a single ultrasound machine can be
used for both diagnosis and treatment. If the practice
already has an active vascular laboratory, an additional
ultrasound machine should be acquired for the vein clinic.
Newer, less expensive, more portable machines are ideal in
this setting.
Initially, a single modality for thermal ablation (laser or
radiofrequency) can be offered, but as the practice grows, it
is preferable to provide the full spectrum of treatment
options for the management of superficial reflux disease,
including endovenous laser ablation, radiofrequency abla-
tion, and ultrasound-guided foam sclerotherapy.13-17 Am-
bulatory phlebectomy and sclerotherapy are used in the
d endovenous thermal ablation systems
odel Type Web site
losure (Plus) RFA www.vnus.com
EVLA www.diomedinc.com
EVLA www.biolitec.com
e EVLA www.angiodynamics.com
C Diode EVLA www.dornier.com
EVLA www.vascularsolutions.com
EVLA www.cooltouch.com
losure (Fast) RFSA www.vnus.com
quency segmental ablation.prove
M
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T
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V
US Ctreatment of residual varicosities,18,19 and these procedures
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revenues.
Additional equipment to add as the practice volume
grows includes the cutaneous laser technology and high-
intensity pulsed light technology that is used in the treat-
ment of telangiectasias.19-21 A detailed description of these
minimally invasive techniques is beyond the scope of this
article.
The decision about which endovascular procedure
should be used is based on the judgment of an experienced
vascular surgeon, in the context of a discussion of the
options with the patient. Faster treatment times combined
with comparable efficiency profile have led some experts to
prefer laser obliteration of the incompetent vein segments
rather than radiofrequency obliteration. A new radiofre-
quency catheter, using the principle of radiofrequency-
powered segmental thermal ablation, was recently devel-
oped in an attempt to overcome these disadvantages. An
increasing amount of clinical data and initial patient satis-
faction support its effectiveness and safety, making this new
technology a favorable alternative to other endovenous
thermal ablation modalities.22
Endovenous ablation systems cost $35,000 to $40,000,
depending on the type and vendor selected.23 Equipment
companies and many other vendors provide supply packages
containing all the necessary components for the procedure.
Different vendors have also different leasing arrangements
that can especially benefit smaller practices. Ideally, a busy
venous practice should operate a noninvasive vascular labora-
tory as a patient convenience and as an important source of
revenue. A handheld portable duplex sonography unit is re-
quired, at the cost of approximately $20,000.23
STAFF
The operation of an outpatient vein clinic requires a
team approach. It is best that the staff is dedicated exclu-
sively to the treatment of venous disorders. An experienced
ultrasonographer, staff assistant, nurse or medical assistant,
and insurance specialist are the minimum. As the practice
grows, productivity can be maximized by the addition of
physician extenders who can perform sclerotherapy, cuta-
neous laser treatments, and in some cases, endovenous
ablations under the supervision of a physician.
Duplex ultrasound imaging is central to the diagnosis
and treatment of venous disease. It is used for diagnosis of
deep and superficial venous insufficiency, pretreatment
mapping of superficial venous system, intraoperative imag-
ing and guidance, and post-treatment assessment of thera-
peutic success and thrombotic states.24-26 In addition to
technical characteristics, diagnostic quality from ultrasound
imaging relies on proper education of the ultrasonogra-
pher. Training in venous reflux evaluation is not a standard
part of the sonographers’ training; therefore, this needs to
be provided by the physician or another sonographer with
venous experience. The ultrasonographer should be able to
understand and recognize the significance of variations in
venous anatomy and pathophysiology and their relation-
ship to treatment options.One of the roles of physician extenders is to optimize
physician productivity. To this end, extenders can perform
sclerotherapy and cutaneous laser therapies and can provide
the initial assessment of patients who are new to the practice
and require a trial of conservative management. Extenders
may also respond to patient telephone calls and provide
continuity of care. This is particularly important when a
rotating surgeon works in the clinic and on days when the
clinic does not have scheduled patient visits.
Administrative staff tasks include completing forms for
insurance preapproval and reimbursement. The importance
of this individual cannot be overstated. Insurance require-
ments for approval of payment are becoming increasingly
strict, have become very complicated, and vary between
insurance payors. Great diligence and organization are
required to make sure that approval takes place as expedi-
tiously as possible and that all documentation required is
provided.
If patient volume grows to exceed the capacity of the
vascular surgeons and extenders within the practice, hiring
a phlebologist may be the most appropriate next step. As a
result of initiatives undertaken by American Collage of
Phlebology, in 2007 the American Board of Medical Spe-
cialties recognized phlebology as a practice specialty, with
its own board examination. This represents a significant
advancement in the care of patients with venous disease,
because no residency-level training currently exists in this
field. Hiring phlebologists into an existing vascular practice
is a new concept. In our practice, the phlebologist has a full
academic appointment and is expected to attend confer-
ences and meetings but does not have hospital admitting
privileges.
REIMBURSEMENT
Reimbursement for the treatment of venous disorders
is generally determined by the third-party payor based on
the patient’s insurance policy and payor guidelines. Given
that geographic location and type of procedure result in
various levels of insurance reimbursement, being familiar
with the variations between medical policies and therapeu-
tic options covered by most insurance plans is very impor-
tant. Coverage is generally limited to patients with compli-
cations of venous disease such as ulceration, phlebitis,
cellulitis, or lifestyle-altering symptomatic venous reflux
that does not respond to conservative therapy. In the latter
case, most insurance companies require a trial of conserva-
tive therapy, consisting of surgical grade class 2 compres-
sion stockings, over-the-counter pain medications, eleva-
tion, and exercise for 3 to 6 months before approving
treatment. Certain insurances companies may even offer
compression stockings as a covered benefit, although most
do not. Most treatment for telangiectasias is considered
cosmetic and is not covered by the insurance.
It is also relevant to learn which providers require
approval before procedures and to establish a system for
obtaining the preapproval. In addition to patient compli-
ance with conservative therapy for the determined period of
time, a successful framework for preauthorization is an
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principles necessary for effective preauthorization are an
understanding of the individual insurance carriers’ definitions
of medical necessity and therapeutic guidelines, providing
complete information detailing physical examination (includ-
ing photographs) and duplex ultrasound findings of substan-
tial reflux, and verifying benefits to include exclusions and
pre-existing medical conditions.
The current payment schema favor performance of
endovenous ablation procedures in a nonfacility site rather
than in a hospital or ambulatory surgery center (Table II).
The performance of ablations in an outpatient vein clinic
with a nonfacility designation can be expected to signifi-
cantly increase revenues and become a profitable addition
to already established vascular surgery practice.27 When
venous ablations are performed in a facility, payment is
divided between the facility (technical component) and the
physician (professional component) and is generally higher
overall than the global fee paid to the physician in a nonfa-
cility. However, the portion of the payment that the phy-
sician receives is a fraction of that paid to the facility. When
venous ablations are performed in a nonfacility, however,
the physician must take on the cost of equipment, space,
and personnel. If the practice owns the space and staff,
revenue is maximized by reducing the cost of equipment
and minimizing staff and space involved.
An alternative scenario is contracting staff and space
from another entity. This is usually done on a per-case basis;
the physician/practice contracts with the site to pay it a
certain amount of money for each case done at the site. In
this case the physician/practice must constantly be vigilant
regarding changes in supply cost and reimbursement and
renegotiate with the site to maintain profitability. For in-
stance, if reimbursement goes down and supply costs are
reduced, the contracted site may fare better, whereas the
physician realizes less revenue. The only caveat to this
paradigm is the situation where the vascular practice is
engaged in a “one dollar model” with the hospital. In this
case, if the vascular practice receives all or a share of the
technical component of a hospital-based procedure, it
would be worthwhile to perform a financial analysis of
revenues generated by facility-based vs nonfacility-based
Table II. National physician payment: facility and office
Type CPT
2009 MD facility
professional fee
(hospital)
2009 MD
(office)a
RFA
1st vein 36475 $335 $1,699
2nd  veins 36476 $164 $365
EVLA
1st vein 36478 $338 $1,400
2nd  veins 36479 $165 $384
CPT, Current Procedural Terminology; EVLA, endovenous laser ablation;
RFA, radiofrequency ablation.
aIncludes costs for all supplies, overhead and physician, nurse and techni-
cian’s time.procedures.Unlike services performed in a hospital-based vascular
surgery practice, outpatient endovenous ablation proce-
dures, the related consultation, and follow-up visits are not
billed globally. Each service (duplex evaluation before and
after procedure, office visits before and after the procedure)
is separately billed. According to the Centers for Medicare
and Medicaid Services for 2009, ultrasound-guided en-
dovenous ablation of an incompetent vein segment per-
formed in the office setting and in the hospital setting has a
national average reimbursement of approximately $2900
and $1700, respectively. Treatment of second and subse-
quent veins has average national reimbursements of ap-
proximately $900 when procedure is performed in the
office settings and $395 when performed in the hospital.
Although profit margins for individual procedures vary
depending on local reimbursement structures, whether
equipment is owned or leased, methods of payment for
support staff, and facility utilization contracts, from our
experience, performing approximately 200 or more proce-
dures a year is associated with a profitable practice.
An additional aspect of the practice to consider is the
self-pay, cosmetic option. This would include patients with
varicose veins with minimal or no symptoms and patients
with spider veins or telangiectasias. Promotion of cosmetic
venous procedures is more challenging than promotion of
most other cosmetic procedures such as liposuction and
rhinoplasty because treatment of venous disease is a cov-
ered service when medically necessary. For this reason,
patients may feel “entitled” to the service as a covered
medical expense. In many patients, a portion of their treat-
ment (ablation of superficial reflux and elimination of
symptomatic varicosities) is appropriately covered, whereas
other treatments (sclerotherapy or laser for spider veins) are
not. In this situation, communication with patients before
treatment about what portion of their service is covered and
why is very important to avoid misunderstanding and con-
flict. A strong marketing campaign is almost always neces-
sary to build and grow a cosmetic aspect of the practice.
PATIENT RECRUITMENT
Some vein practices may generate more than enough
volume without using strategies for patient recruitment,
but others may find that marketing is necessary to build and
maintain a busy practice. This is especially true in areas
where competition is greatest, such as in heavily populated
urban areas. Depending on the need and the individual
business plan of each vein clinic, promotion and advertising
can be contracted to independent companies or accom-
plished through the parent institution. In addition to tra-
ditional marketing techniques such as print, television, and
radio media, other less costly ways to promote the practice
are the creation of an informational Web site and working
with professional societies such as the Society for Vascular
Surgery or the American College of Phlebology. These
societies can help increase exposure and referrals by linking
the vein clinic profile with their Web site and other sources
of their advertisement. The benefits of advertising can be
striking, because venous disorders are an extremely com-
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cians are unaware of the treatment possibilities. Moreover,
venous disorders are increasing in prevalence as a result of
increasing life expectancy.
DISCUSSION
Great progress has been made in the management of
venous reflux disease in the last decade. Intensive research
on pathogenesis, development of the CEAP classification,
advancements in imaging techniques, and new therapeutic
options have led to substantial changes in the understand-
ing of venous disorders as well as advances in the available
therapeutic options. The development of endovenous ther-
mal ablation techniques provides a number of effective,
outpatient procedures that are associated with minimal
morbidity and a short recovery period. This affords the
opportunity not just to treat young healthy patients but
also allows us to treat patients who were previously consid-
ered not to be operative candidates, such as octogenarians
and patients with coexisting medical conditions and pro-
hibitive surgical risk factors. The continued development of
endovenous technologies can be expected to yield an even
bigger array of safe and effective minimally invasive treat-
ment options.
In addition to improved efficiency of care, an outpatient
vein clinic can provide a significant source of revenue, espe-
cially if procedures are performed in a nonfacility setting.
Professional revenue ismore limitedwithin the hospital-based
clinic setting for services reimbursed by insurance.
As office-based practices in venous disease continue to
expand due to the advent of minimally invasive methods,
increased patient interest and financial incentives, vascular
surgeons must keep up with this change to provide venous
patients with comprehensive, well-informed care. Separa-
tion of the arterial and venous practices allows for focused
care of the venous patient by staff dedicated to these
disorders, a better treatment environment for patients, and
protection of time needed to maintain the arterial practice.
Having an additional day of clinic time specifically dedi-
cated to venous patients assures that operating the vein
clinic does not interfere with the treatment of nonvenous
patients and other academic activities.
Positive patient experience leads to the development of
strong long-term patient–physician relationships, improves
patient compliance with therapy, and generates patient-to-
patient referrals. Vascular surgeons considering the forma-
tion of a distinct vein clinic should be prepared for an
expansion of the physician and ancillary staff workload as a
large number of patients may inquire about treatment for
venous disease.28-30 Adding physician extenders with an
interest in venous disease, and even a phlebologist, can
maximize the productivity of the vascular surgeons in the
practice.
Because most venous procedures can now be done
percutaneously or with simple surgical techniques, physi-
cians from a wide variety of backgrounds, including family
medicine, obstetrics/gynecology, general surgery, and an-
esthesiology are performing venous procedures. In manycases, the training that these individuals receive is far short
of what is appropriate. There has been a strong move by
both insurance payors and national professional societies
such as the American College of Phlebology to develop
and enforce specific criteria for credentialing in phle-
bology. This includes board certification in phlebology,
which has recently been recognized by the American
Board of Medical Specialties. The first examination was
given in 2008.
CONCLUSIONS
Incorporating outpatient venous procedures into an
existing vascular surgery practice results in optimal patient
care while increasing practice revenues. With the proper
planning and organization, the addition of a venous prac-
tice into an established vascular surgery practice can be
successful. The key components of this process are selection
of optimal nonfacility space, separation of arterial and ve-
nous practices, developing experienced, dedicated venous
staff, developing expertise in negotiating the reimburse-
ment labyrinth, and offering a full range of venous proce-
dures. In addition to providing streamlined and compre-
hensive care and generating revenue, a successful vein
practice can also help generate referrals for the arterial side
of the vascular practice. It is incumbent upon vascular
surgeons to take ownership of the care of patients with
venous disease, because it is vascular surgeons alone who
combine the knowledge and technical expertise to treat all
aspects of venous disorders.
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